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Abstract 
 
The aim of the study was to assess the between-day reliability and validity of a medicine ball 
contained-accelerometer (MBA) for assessing upper-body neuromuscular performance during 
a throwing task. Ten professional rugby union players partook in the study. Between-day 
reliability was assessed from the best score attained during 2 sets of 3 throws, on 2 testing 
occasions separated by 7 days. Validity was assessed against a criterion measure 
(Optioelectronic system) during 75 throws from a sub group of three participants. The MBA 
exhibited a small between-day error of 2.2 % (90% CI’s; 2.0 to 4.6 %) and an almost perfect 
relationship with a criterion measure r = 0.91 (90% CI’s; 0.87 to 0.94)). However, the mean 
bias and standard error were moderate (7.9% (90% CI’s; 6.6 to 9.2%) and 4.9% (90% CI’s; 4.2 
to 5.7%) respectively). Practitioners using an MBA to assess neuromuscular performance of 
the upper-body must take into account the overestimation and error associated with such 
assessment with respect to a criterion measure. However, as the error associated with between-
day testing was small, and testing is easy to implement in applied practice, an MBA may 
provide a useful tool for monitoring upper-body neuromuscular performance over time.  
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Introduction 
 
Professional sport relies on many different technologies to quantify and monitor training 
outputs, and provide feedback to coaches and athletes (6). Examples include the use of global 
positioning systems (GPS) for monitoring distances, velocities and accelerations (2), timing 
gates to monitor linear speed (7) and linear position transducers to provide force, velocity and 
power of barbell lifts (9). However, practitioners regularly use new technology without 
understanding the validity and reliability of the devices in use (6). Recently a new technology 
allowing measurement of velocity from medicine ball throws has been made available to 
practitioners. This may offer a diagnostic tool for the assessment of upper-body neuromuscular 
performance, which is important for monitoring fatigue (8), measuring and tracking 
performance (10) and use in upper-limb rehabilitation programmes (1). However, this 
technology is yet to be validated, or assessed for reliability. Therefore, the aim of the present 
study was to examine the between-day reliability and validity of a medicine ball-contained 
accelerometer (MBA) for assessing throwing velocity during an upper-body power exercise.  
 
Methods 
 
Subjects  
 
Ten male professional rugby union players (age 19.7±1.1 years, body mass 98.3±13.2kg, height 
186.2±7.6cm) were recruited from a professional rugby union club. All players were in their 
second year of their professional contracts. Testing was undertaken during the preseason 
period, throughout which subjects typically engaged in 8 individual training sessions across 5 
days per week including 2 upper-body and 2 lower-body resistance training sessions, along 
with rugby skills training and conditioning. Subjects were excluded if they had a current upper-
limb injury, or history of upper-limb injury that prevented them from performing the testing 
procedure. Ethics approval was granted by University ethics board and informed consent was 
acquired from all participants.  
 
Design  
 
Reliability data of the 8 kg medicine ball-contained accelerometer (MBA; Ballistic Ball, 
Assess2Perform, USA) was collected on two separate days (7 days apart) during a week at the 
end of the playing season. Testing was undertaken at the same time of day to ensure diurnal 
variation did not affect performance. All participants were provided with regular dietary advice 
from the club’s nutritionist, but dietary intake was not controlled for in the present study. 
Subjects had approximately 48 hours rest prior to each testing session. Subjects were in a 
supine position on the floor, on their back with hips and knees bent to approximately 45 degrees 
and feet flat on the floor. The MBA was held with elbows extended and hands supporting the 
medicine ball from underneath. Elbow width was at the discretion of the participant. Subjects 
were instructed to throw the MBA into the air as hard as possible without their feet, buttocks, 
back or shoulders leaving the floor. Subjects performed two sets of three throws. Intra-set rest 
was approximately 20 seconds while inter-set rest was 2 minutes. The highest score achieved 
was used in the final analysis.  
 
The validity of the MBA was assessed against a criterion measure (Optioelectronic system; 
Qualisys – Qqus system, software version 2.14) in a University biomechanics laboratory, 
where three subjects performed 25 throws each. Five (18mm) reflective markers were attached 
to the MBA (superior, inferior poles, and a 3-marker cluster on the anterior face) and were 
tracked during each throw using 8 Qualisys cameras sampling at 200Hz. The kinematic data 
were processed and filtered in Qualisys, before data was transferred to Visual 3D (version 6). 
In Visual 3D, the 5 tracking markers were used to create three virtual markers within the MBA 
centre (offset 50% between superior and inferior markers). Anterior split (offset 50% between 
two cluster tracking markers, on a plane with the med ball centre) and anterior y (offset 50% 
between the top cluster marker and the anterior split marker). A virtual segment was then 
created for the MBA using these virtual markers. The advantage of creating virtual markers to 
track the objects kinematics is to minimise any error that may come from one marker moving 
or shifting on the surface of the MBA. A pipeline (segment velocity) was used to extract the 
velocity signal for segment 'med ball' against the 'laboratory' as a reference. The peak velocity 
achieved during the upward phase of the throw was used for analysis against the MBA’s output.  
 
Statistical Analysis 
 
The between-day reliability statistic of typical error (TE) was calculated as; Sdiff / √2 where 
Sdiff is the standard deviation of the difference score and converted to a coefficient of variation 
(CV; TE expressed as a percentage) for all tests using a Microsoft Excel spreadsheet (4). The 
standardised typical error was rated as trivial (<0.19), small (0.2-0.59), medium (0.6-1.19) or 
large (1.2-1.99) (4). The smallest worthwhile change was calculated as 0.2 multiplied by the 
between-subject standard deviation and calculated as a percentage of the mean (5). The 
agreement between the criterion measure (Qualisys) and the practical measure (MBA) was 
assessed using an excel spreadsheet (4) designed to calculate the mean bias ([x  / x  ] x 100), 
standard error of the estimate (STEXY function) and Pearson correlation coefficient, all with 
90% confidence limits (4). The mean bias and standard error were standardised using the SD 
of the criterion to allow for qualitative rating. The standardised mean bias was rated as trivial 
(<0.19), small (0.2-0.59), medium (0.6-1.19) or large (1.2-1.99) (4). The standardised standard 
error was rated as trivial (<0.1), small (0.1-0.29), moderate (0.3-0.59) or large (>0.59).(4) The 
magnitude of correlation was rated as trivial (<0.1), small (0.1-0.29), moderate (0.3-0.49), 
large (0.5-0.69), very large (0.7-0.89) or nearly perfect (0.9-0.99) (4).  
 
Results 
 
The between-day CV of the test was 2.2 % (2.0 to 4.6 %) (raw; 0.11 m/s ( 0.10 to 0.23 m/s)) 
and was rated as small. The smallest worthwhile change was 1.5% (raw; 0.07 m/s). When the 
medicine ball was compared to the criterion measure, mean bias was moderate (7.9% (6.6 to 
9.2%), raw; 0.39 m/s (0.33 to 0.45 m/s)), typical error of the estimate was moderate (4.9% (4.2 
to 5.7%), raw; 0.24 m/s (0.21 to 0.28 m/s)), while the correlation was almost perfect (r = 0.91 
(0.87 to 0.94)). The regression plot is presented in Figure 1.  
 
The regression equation to estimate the criterion measure (Y) from the practical measure (X) 
is:  
Y = intercept + (slope x X)  
Y = 0.948 + (0.648 x X)  
 
***INSERT FIGURE 1 HERE*** 
 
Discussion 
 
This study examined the reliability and validity of a MBA for assessing throwing velocity 
during an upper-body power exercise. Between-day reliability analysis revealed a small typical 
error of 2.8 % (2.0 to 4.6). Practitioners wishing to track upper-body neuromuscular 
performance over time using an MBA can use this statistic to assess if a meaningful change 
has occurred. Hopkins (3) proposed a method whereby the change score of an individual (± 
error bars representing the CV) is graphed with an important threshold (e.g. the smallest 
worthwhile change). A change is ‘clear’ when the error bars lie outside of the important 
threshold and ‘unclear’ when the error bars cross the important threshold (3). It must be pointed 
out that the subjects in this study were trained athletes, and as such, the between-day error may 
be different for other populations of different training backgrounds and athletic abilities.  
 
***INSERT FIGURE 2 HERE*** 
 
In addition, correlation analysis demonstrated an almost perfect relationship between the MBA 
and criterion measure, indicating excellent validity. However, the findings show that the MBA 
overestimated throwing velocity by 7.9%, and demonstrated a moderate standard error (4.9%) 
when compared to the criterion measure. Therefore, practitioners using an MBA to measure 
upper-body neuromuscular performance must take into account the error and bias when making 
inferences about such performance. Practitioners wishing to estimate the criterion from the 
MBA may do so using the equation provided, while appreciating the associated error with this.  
 
Practical applica tions 
 
Practitioners using an MBA to assess neuromuscular performance of the upper-body must take 
into account the overestimation and error associated with such assessment with respect to a 
criterion measure. However, as the error associated with between-day testing was small, and 
testing is easy to implement in applied practice, an MBA may provide a useful tool for 
monitoring upper-body neuromuscular performance over time in trained athletes.  
 
Conclusion 
 
This study investigated the reliability and validity of a medicine ball-contained accelerometer 
for measuring throwing velocity during a throwing task. Although it exhibited an almost perfect 
relationship with a criterion measure, it moderately overestimated throwing velocity and had a 
moderate standard error. Despite this, the between-day assessment error was only small, 
making it a potentially useful test to monitor changes in upper-body neuromuscular 
performance over time in trained athletes.  
 
References  
 
Borms D, Maenhout A, and Cools AM. Upper Quadrant Field Tests and Isokinetic Upper Limb 
Strength in Overhead Athletes. J Athl Train 51: 789-796, 2016.  
 
Cummins C, Orr R, O'Connor H, and West C. Global positioning systems (GPS) and 
microtechnology sensors in team sports: a systematic review. Sports Med 43: 1025-1042, 2013.  
 
Hopkins WG. How to Interpret Changes in an Athletic Performance Test. Sportscience: 1-7, 
2004.  
 
Hopkins WG. Spreadsheets for analysis of validity and reliability, in: Sportscience. 
sportsci.org/2015/ValidRely.htm, 2015, pp 36-42. 
 
Hopkins WG, Marshall SW, Batterham AM, and Hanin J. Progressive statistics for studies in 
sports medicine and exercise science. Med Sci Sports Exerc 41: 3-13, 2009.  
 
Malone JJ, Lovell R, Varley MC, and Coutts AJ. Unpacking the Black Box: Applications and 
Considerations for Using GPS Devices in Sport. Int J Sports Physiol Perform 12: S218-s226, 
2017. 
 
Roe G, Darrall-Jones J, Black C, Shaw W, Till K, and Jones B. Validity of 10 HZ GPS and 
Timing Gates for Assessing Maximum Velocity in Professional Rugby Union Players. Int J 
Sports Physiol Perform: 1-14, 2016.  
 
Roe G, Darrall-Jones J, Till K, Phibbs P, Read D, Weakley J, and Jones B. Between- Days 
Reliability and Sensitivity of Common Fatigue Measures in Rugby Players. Int J Sports Physiol 
Perform 11: 581-586, 2016. 
 
Scott BR, Duthie GM, Thornton HR, and Dascombe BJ. Training Monitoring for Resistance 
Exercise: Theory and Applications. Sports Med 46: 687-698, 2016. Wang R,  
 
Hoffman JR, Sadres E, Bartolomei S, Muddle TWD, Fukuda DH, and Stout JR. Evaluating 
Upper-Body Strength and Power From a Single Test: The Ballistic Push-up. J Strength Cond 
Res 31: 1338-1345, 2017.  
 
 
Figure 1. Regression plot for agreement between the criterion measure (Qualisys) and the 
practical measure (medicine ball).  
 
Figure 2: An example of change in the performance of 2 athletes. Data are percentage change 
in an individual’s performance (± CV error bars) with grey area representing the smallest 
worthwhile change. Adapted from Hopkins (3).  
 
